Michael Price is known to prefer out-of-favor small cap companies that offer good value when he makes his investment decisions, and many of his third-quarter transactions fit that description, but some of his largest transactions involved companies with caps that exceeded several billion dollars. A good example is Price's most significant third-quarter transaction the sale of his 400,000-share stake in Hospira Inc. , a Lake Forest, Illinois-based pharmaceutical and medical device company, for an average price of $89.48 per share.